[Stress ulcer disease and its prevention]

Area of Science:

• Critical Care Medicine
• Gastroenterology
• Pharmacology

Background:

• Acute gastroduodenal stress lesions are common in critically ill patients.
• While the incidence of stress ulcer bleeding has decreased, predicting individual patient risk remains difficult.
• Well-defined patient groups, such as those on mechanical ventilation, are prone to stress ulcer disease.

Purpose of the Study:

• To analyze the incidence and prophylaxis of stress ulcer disease.
• To evaluate the effectiveness of different prophylactic agents.
• To explore the relationship between gastric pH control and prophylactic efficacy.

Main Methods:

• Review of incidence and prophylaxis strategies for stress ulcer disease.
• Analysis of data on critically ill patients, including those on mechanical ventilation.
• Comparison of prophylactic agents such as antacids, H2-receptor antagonists, pirenzepine, and sucralfate.

Main Results:

• Prophylaxis with antacids, H2-receptor antagonists, pirenzepine, and sucralfate appears equally effective in reducing stress ulcer bleeding.
• Prophylactic efficacy does not strongly correlate with the ability to maintain gastric pH above 4.
• Higher placebo-induced bleeding rates correlate with better prophylactic treatment efficacy.

Conclusions:

• Various prophylactic treatments are effective in reducing stress ulcer bleeding in at-risk patients.
• Gastric acid secretion blockers may be linked to increased nosocomial pneumonia, requiring further investigation.
• Individual risk assessment for stress ulcer disease requires further research despite defined at-risk groups.